Sign Up to Receive the Latest Trading Tips and News from Prosper

    October 4, 2018

    Mallinckrodt Pharmaceuticals Is In Need Of Its Own Medicine

    Both biotech and healthcare stocks were sharply lower overall in today’s session. Overall, US equities markets sold sharply off recent all-time highs as reality finally set in that interest rates would likely continue higher due to persistently positive economic data. One stock hit particularly hard today is Mallinckrodt (MNK), which traded down over 17.50%. Besides […]

    Read Article